All-oral 12-week combination treatment with daclatasvir (DCV) and sofosbuvir (SOF) in treatmentexperienced patients infected with HCV genotype (GT) 3: A subanalysis of the ALLY-3 phase 3 study

Authors
Category Primary study
JournalJournal of Hepatology
Year 2015
This article has no abstract
Epistemonikos ID: dc57f2683a95ea3b77ca5453e0bcc8159b70a195
First added on: Feb 07, 2025